Sunesis Pharmaceuticals (SNSS) Tops Q2 EPS by 3c
Tweet Send to a Friend
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q2 EPS of ($0.18), $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
